Jennifer specialises in complex and high-value patent portfolio creation and management and IP strategy in the chemical sector. Her practice focuses on strategic drafting and prosecution of patent applications before the EPO and UKIPO, advising on issues relating to supplementary protection certificates (SPCs), and the management of international patent filing and prosecution strategies. She also regularly acts to protect her clients’ interests in hearings at the EPO in pre-grant, opposition and appeal proceedings.
In terms of technology, Jennifer works across the chemical field, with a particular focus in the areas of pharmaceutical chemistry, drug delivery formulations, synthetic methods, polymers and composite materials.
Jennifer’s expertise includes assisting clients in the pharmaceutical sector at all stages of the drug development process, from invention capture and original patent drafting, through to managing complex patent portfolios for high value clinical trial candidates and marketed drug products. She also has significant experience advising on infringement and validity issues and regularly assists clients with commercially important due diligence projects.
Jennifer is recognised by all of the leading legal directories, including Chambers & Partners, Legal 500, Managing IP, IAM Patent 1000, and JUVE. She has also been recognised by IAM Strategy 300 as one of the world’s leading IP strategists.
Year joined the firm: 2006
